Healthcare -
Biotechnology - NASDAQ - US
$ 5.44
2.84 %
$ 350 M
Market Cap
-5.49
P/E
CRVS - OTHER FINANCING ACTIVITIES
Other Financing Activities CRVS - Corvus Pharmaceuticals, Inc.
24 K
LAST VALUE
-85.95%
2 YEAR CAGR
-42.83%
5 YEAR CAGR
0.00%
10 YEAR CAGR